Preservation of salivary gland function using low dose amifostine in thyroid cancer patients receiving radioiodine therapy

被引：0
|
作者：
Haindl, W
Frater, CJ
Taylor, JE
Rossleigh, MA
机构：
[1] Prince Wales Hosp, Dept Nucl Med, Sydney, NSW, Australia
[2] Nucl Diagnost Randwick, Sydney, NSW, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [1] Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer
    Bohuslavizki, KH
    Klutmann, S
    Bleckmann, C
    Brenner, W
    Lassmann, S
    Mester, J
    Henze, E
    Clausen, M
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (02) : 57 - 61
  • [2] Salivary gland function in thyroid cancer patients submitted to radioiodine therapy
    Almeida, J.
    Sanabria, A.
    Lima, E.
    Kowalski, L. P.
    [J]. ORAL ONCOLOGY, 2007, : 219 - 219
  • [3] Does the Use of Amifostine for Salivary Gland Protection Reduce the Rate of Thyroid Remnant Ablation in Patients with Differentiated Thyroid Cancer Receiving Radioiodine Therapy?
    Haindl, W.
    Ting, A. C. C.
    Rossleigh, M. A.
    Som, S. S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S122 - S122
  • [4] Quantitative assessment of salivary gland function in thyroid cancer patients after radioiodine therapy
    Fard-Estahani, A
    Olamie, R
    Eftekhari, M
    Saghari, M
    Fallahi, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S23 - S24
  • [5] Quantification of salivary gland function in thyroid cancer patients treated with radioiodine
    Malpani, BL
    Samuel, AM
    Ray, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (03): : 535 - 540
  • [6] Salivary gland function in thyroid cancer patients with radioiodine administration history
    Krcalova, Eva
    Horacek, Jiri
    Gabalec, Filip
    Zak, Pavel
    Dolezal, Jiri
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (03): : 277 - 283
  • [7] Amifostine Used Clinically for Salivary Gland Protection during Therapy with Radioiodine Is Cytotoxic for Thyroid Cancer Cells
    Klubo-Gwiezdzinska, Joanna
    Costello, John
    Jensen, Kirk Ernest
    Patel, Aneeta
    Van Nostrand, Douglas
    Burman, Kenneth
    Wartofsky, Leonard
    Vasko, Vasyl
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Karimi, Mohammad
    Beiki, Davood
    Saghari, Mohsen
    Emami-Ardekani, Alireza
    Fard-Esfahani, Pezhman
    Ansari, Mojtaba
    Eftekhari, Mohammad
    [J]. IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 23 (01): : 1 - 7
  • [9] Salivary Gland Malignancy and Radioiodine Therapy for Thyroid Cancer
    Klubo-Gwiezdzinska, Joanna
    Van Nostrand, Douglas
    Burman, Kenneth D.
    Vasko, Vasyl
    Chia, Stanley
    Deng, Tom
    Kulkarni, Kanchan
    Wartofsky, Leonard
    [J]. THYROID, 2010, 20 (06) : 647 - 651
  • [10] Salivary gland toxicity after radioiodine therapy for thyroid cancer
    Hyer, S.
    Kong, A.
    Pratt, B.
    Harmer, C.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (01) : 83 - 86
12345